AzTrials
AzTrials

DepressionNCT06770075

Brightline: Advancing Mental Health on Campus

An observational study of Depression and Anxiety, run by Nanyang Technological University at 1 site in Singapore.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This observational study will employ a multi-modal observation methodology, integrating data from wearable devices and smartphones to establish comprehensive digital biomarkers for identifying symptoms of mental health conditions in university students. Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
Conditions the study is for
Depression, Anxiety, Stress
What is being tested?
Observational
How many people
500 participants
Where
1 siteSingapore
Study dates
Jan 2025to Mar 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Undergraduate students

Who may be able to join

  • Be aged 18 years or older.
  • Be a current full-time undergraduate student.
  • Own a smartphone with Wi-Fi, 4G, and Bluetooth capabilities.
  • Possess adequate English language proficiency.
  • Be able to download the study apps.
  • Provide informed consent.

Who cannot join

  • Are part-time students.
  • Have a current diagnosis of any mental health disorder or a past diagnosis with any bipolar disorder, substance use disorder, or any psychotic disorder.
  • Are currently undergoing mental health treatment.
  • Lack sufficient English proficiency.
  • Report suicidal ideation as indicated by Patient Health Questionnaire (PHQ-9) Item-9, "Thoughts you would be better off dead or of hurting yourself in some way".
  • Cannot commit to wearing a wearable device for the six-month monitoring period.
  • Receive special education accommodations or support from the university.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Zhi Wei Tan, PhD contact

+65 92312575

zhiwei.tan@ntu.edu.sg

Singapore1 site, 1 recruiting
  • Nanyang Technological University

    Singapore, 639798

    Zhi Wei Tan, PhD, +65 92312575, zhiwei.tan@ntu.edu.sg

    Andy WH Khong, PhD

    Recruiting

Other trials in Singapore

About this study

Official title: Brightline - a Digital Phenotyping Study Toward Advancing Mental Health on Campus

This observational study will employ a multi-modal observation methodology, integrating data from wearable devices and smartphones to establish comprehensive digital biomarkers for identifying symptoms of mental health conditions in university students. The study aims to identify the digital behavioural markers associated with mental health conditions, develop predictive algorithms for mental health states from digital markers, and identify university students at risk for mental health conditions.

Read the detailed description

In this study, participants will be monitored over a six-month period to determine the association between digital behavioural markers and mental health symptoms among university students. Participants will be passively monitored to collect digital phenotyping data (e.g., physical activity, sleep activity, heart rate, physiological patterns, sociability indices, finger taps, ambient light, phone states, etc.), using a wearable device and sensors from the smartphone. Participants will also complete self-report questionnaires at Months 0, 1, 3, and 6, to track changes in mental health symptoms and behavioural data. The collected data will be analysed to examine the longitudinal changes in depression, anxiety, and other mental health issues among university students and explore the feasibility of data collection procedures.

Being tested
Observational
Keywords
university student, mental health, digital phenotyping, digital biomarkers, passive sensing, risk prediction, mental health seeking
Medical subject headings
Depression, Anxiety Disorders, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ObservationalOther

    Also called There will be no interventions involved in this study.

    Participants will not receive any study intervention. During the six month study period, participants will complete four active assessments at Months 0, 1, 3 and 6, and data from the study-provided wearable (Fitbit Charge 6) and sensors from the participant's smartphone (through the Brightline app) will be collected passively throughout.

Study groups in NCT06770075
Study groupRoleWhat they receive
Undergraduate studentsUndergraduate students from Nanyang Technological University
Receives: Other: Observational

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patient Health Questionnaire-9 (PHQ-9)

    A nine-item scale assessing depression severity. A higher total score indicates increased depression severity.

    Measured: Baseline (Month 0), Interim (Month 1), Mid-point (Month 3), End-point (Month 6)

Secondary outcomes (7)
  1. Generalized Anxiety Disorder-7 (GAD-7)

    A seven-item scale assessing anxiety severity. A higher total score indicates increased anxiety severity.

    Measured: Baseline (Month 0), Interim (Month 1), Mid-point (Month 3), End-point (Month 6)

  2. Perceived Stress Scale 4 (PSS-4)

    A four-item scale assessing stress severity. A higher total score indicates increased stress severity.

    Measured: Baseline (Month 0), Interim (Month 1), Mid-point (Month 3), End-point (Month 6)

  3. International Positive and Negative Affect Schedule - Short Form (I-PANAS-SF)

    A ten-item scale divided into two subscales, assessing subjective experiences of positive and negative affect. A higher total score on each subscale indicates increased positive or negative affect.

    Measured: Baseline (Month 0), Interim (Month 1), Mid-point (Month 3), End-point (Month 6)

  4. University of California Los Angeles, 3-Item Loneliness Scale (UCLA-3)

    A three-item scale assessing levels of loneliness. A higher total score indicates increased loneliness.

    Measured: Baseline (Month 0), Interim (Month 1), Mid-point (Month 3), End-point (Month 6)

  5. University Stress Scale (USS)

    A 21-item scale assessing the degree to which university life events are perceived as stressful. A higher score indicates increased perceived stress.

    Measured: Baseline (Month 0), Interim (Month 1), Mid-point (Month 3), End-point (Month 6)

  6. Mental Help Seeking Attitudes Scale (MHSAS)

    A nine-item scale assessing attitudes towards seeking mental health help. A higher score indicates more favorable attitudes towards seeking mental health assistance.

    Measured: Baseline (Month 0), End-point (Month 6)

  7. Perceptions of study compliance

    Participants will be evaluated on five items assessing the acceptability of the study procedure, specifically related to wearing the wearable device. Additionally, they will be provided a free-text response to details any difficulties or challenges encountered during the study period.

    Measured: End-point (Month 6)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2025
  2. Study startJan 2025 (estimated)
  3. Primary completionDec 2025 (estimated)
  4. Study completionMar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06770075
Sponsor's protocol ID
IRB-2023-894
Status last verified
Jan 2025
First submitted
9 Jan 2025
Last updated
15 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ito S, Ang CS, Kampman OP, Rokde K, Buddhika T, Heaukulani C, Tan ZW, Dewanti FA, Au EWM, Huan VS, Morris RJ, Khong AWH, Ho AHY. Harnessing digital phenotyping to advance university student mental health (Brightline) in Singapore: study protocol for a prospective observational study. BMJ Open. 2025 Sep 22;15(9):e103652. doi: 10.1136/bmjopen-2025-103652.

    PubMed 40983586

Questions about this trial

What is this clinical trial studying?

An observational study of Depression and Anxiety, run by Nanyang Technological University at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 15 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zhi Wei Tan, PhD (+65 92312575, zhiwei.tan@ntu.edu.sg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patient Health Questionnaire-9 (PHQ-9) (time frame: Baseline (Month 0), Interim (Month 1), Mid-point (Month 3), End-point (Month 6)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06770075, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in